This inventor holds 0 USPTO granted patents, plus 13 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Dong Liu: Innovator in Image Aesthetics and Nanoparticle Technologies
Introduction
Dong Liu is a notable inventor based in the United States. He has made significant contributions to the fields of image processing and pharmaceutical technologies. His innovative work has led to the development of advanced methods and compositions that enhance the aesthetic evaluation of digital images and improve drug formulation processes.
Latest Patents
Dong Liu holds several patents, including "Identifying Image Aesthetics Using Region Composition Graphs." This computer-implemented method involves generating a three-dimensional (3D) feature map for a digital image using a fully convolutional network (FCN). The method identifies features of the digital image and generates a region composition graph that models mutual dependencies between these features. Additionally, he has developed "Compositions And Methods For Nanoparticle Lyophile Forms," which provides compositions for creating solid lyophiles of nucleic acid active agents. These compositions can be reconstituted as drug products, encapsulating RNAi molecules and other nucleic acids within lipid nanoparticles.
Career Highlights
Throughout his career, Dong Liu has worked with various companies, including Eternity Bioscience Inc. and Enanta Pharmaceuticals, Inc. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in biotechnology and pharmaceuticals.
Collaborations
Dong Liu has collaborated with notable professionals in his field, including Minsheng Zhang and Yiyin Ku. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Dong Liu is a distinguished inventor whose work in image aesthetics and nanoparticle technologies has made a significant impact in his fields. His innovative patents and collaborations highlight his commitment to advancing technology and improving drug formulations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile